Da celecoxib overvejende metaboliseres af CYP2C9, bør det bruges i halvdelen af den anbefalede dosis hos patienter, som får fluconazol.
Since celecoxib is predominantly metabolised by CYP2C9 it should be used at half the recommended dose in patients receiving fluconazole.